Cocrystal Pharma reduces stockholder meeting quorum to one-third

Cocrystal Pharma, Inc.

Board approved bylaw amendment on June 17, 2025 reducing quorum to one-third of voting power.
Quorum now requires one-third of outstanding shares entitled to vote, down from majority.
Amendment effective immediately; full text filed as Exhibit 3.1.
No other changes to bylaws or fiscal year were made.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Cocrystal Pharma, Inc.: Amended the quorum requirement to one third of the voting power of outstanding shares of all classes or series of voting stock (effective 2025-06-17).

Change: bylaw amendment
Effective: 2025-06-17

Exact text from the filing

On June 17, 2025, the Board of Directors of Cocrystal Pharma, Inc. (the “Company”) approved an amendment to the Company’s Amended and Restated Bylaws to the quorum requirement to provide that one third of the aggregate voting power of the outstanding shares of all classes or series of voting stock then entitled to vote, represented in person or by proxy, shall constitute a quorum at a meeting of stockholders (the “Amendment”).

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

Cocrystal Pharma, Inc. filing history →

Source: SEC EDGAR

accession 0001641172-25-015571

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.